A new test provides a much more complete picture of DNA than current standard diagnostics and leads to a diagnosis more often. The test can replace fifteen other tests, making it faster and more ...
Research highlights how ExomeReveal RNA analysis resolves ambiguity around uncertain variants to enable more genetic disease diagnoses Ambry Genetics, a leader in clinical genomic testing, and a ...
Ambry Genetics’ HQ in Aliso Viejo has about 270 of its 1,000 companywide employees New research suggests that Ambry Genetics’ RNA analysis can improve the accuracy of exome testing. The study, ...
SNPS is down 1% YTD at $465, despite 42% revenue growth, as Ansys acquisition debt and a Zacks Sell rating weigh on sentiment. Norges Bank's new $730 million stake and Samsung Foundry's AI design ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results